Sep. 24—(StatePoint) Getting the correct treatment for bronchiectasis, a chronic lung condition affecting 350,000 to 500,000 adults nationwide, is necessary to slow disease progression and help ...

The MHRA has licensed brensocatib as the first disease-specific therapy for non-cystic fibrosis bronchiectasis in patients with recurrent exacerbations.

The Medicines and Healthcare products Regulatory Agency has granted marketing authorisation for brensocatib, branded as ...

Notable signs and symptoms distinguishing bronchiectasis from other pulmonary disease states are discussed. This is a video synopsis/summary of an Insights involving Mark Metersky, MD, FCCP, on the ...

Please provide your email address to receive an email when new articles are posted on . Indigenous ethnicity and new abnormal auscultatory signs raised the odds for symptom resolution after antibiotic ...

Bronchiectasis, a condition defined by widened lung airways, cough and sputum production, and frequent infections, often presents along with chronic obstructive pulmonary disease (COPD). This overlap ...

Mark Metersky, MD, FCCP, illustrates the pathology of bronchiectasis. This is a video synopsis/summary of an Insights involving Mark Metersky, MD, FCCP, on bronchiectasis. Bronchiectasis is an ...

*Refers to the latest 2 years of stltoday.com stories. Cancel anytime. Dear Dr. Donohue - For two years, I had a cough that was constant. I didn't feel all that sick, and I saw a number of doctors ...